Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New data from M. Dede et al illuminate research in breast cancer
May 1st, 2008
According to a study from Ankara, Turkey, "As is known, tamoxifen therapy is related to endometrial proliferation, hyperplasia, polyp formation, invasive carcinoma and uterine sarcoma." "In this study, we present a 75-year-old woman who had five children. Gastric tumor, endometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with tamoxifen for breast cancer," wrote M. Dede and colleagues. The researchers concluded: "It seems that being aware of the undersirable affects of tamoxifen treatment during the chemotherapy and post-chemotherapy period is very important." Dede and colleagues published the...
Source: Women's Health Weekly (2008-05-01)
|
